Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:21 pm Sale | 2024-09-30 | 13G | ASTRIA THERAPEUTICS INC ATXS | TCG Crossover GP II, LLC | 2,761,861 4.900% | -1,607,067 (-36.78%) | Filing History |
| 2024-11-07 4:27 pm Purchase | 2024-10-31 | 13G | EYEPOINT INC EYPT | TCG Crossover GP II, LLC | 3,572,335 5.200% | 3,572,335 (New Position) | Filing History |
| 2024-09-27 4:52 pm Purchase | 2024-09-18 | 13G | THIRD HARMONIC BIO INC THRD | TCG Crossover GP II, LLC | 2,415,000 5.900% | 2,415,000 (New Position) | Filing History |
| 2024-09-20 4:21 pm Purchase | 2024-09-12 | 13G | FULCRUM THERAPEUTICS INC FULC | TCG Crossover GP II, LLC | 5,000,000 9.400% | 5,000,000 (New Position) | Filing History |
| 2024-08-26 6:49 pm Purchase | 2024-08-14 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | TCG Crossover GP II, LLC | 4,643,812 6.800% | 4,643,812 (New Position) | Filing History |
| 2024-03-15 4:18 pm Purchase | 2024-03-06 | 13G | NEKTAR THERAPEUTICS NKTR | TCG Crossover GP II, LLC | 1,336,423 9.900% | 1,336,423 (New Position) | Filing History |
| 2024-02-15 4:20 pm Purchase | 2024-02-12 | 13G | MINERALYS THERAPEUTICS INC MLYS | TCG Crossover GP II, LLC | 3,185,185 6.400% | 3,185,185 (New Position) | Filing History |
| 2024-02-15 4:17 pm Purchase | 2024-02-08 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | TCG Crossover GP II, LLC | 2,076,357 9.900% | 2,076,357 (New Position) | Filing History |
| 2024-01-16 4:18 pm Purchase | 2024-01-05 | 13G | ASTRIA THERAPEUTICS INC ATXS | TCG Crossover GP II, LLC | 4,368,928 9.900% | 4,368,928 (New Position) | Filing History |
| 2023-10-16 4:37 pm Purchase | 2023-10-04 | 13G | VISTAGEN THERAPEUTICS INC VTGN | TCG Crossover GP II, LLC | 2,702,157 9.900% | 2,702,157 (New Position) | Filing History |